Early initiation of extracorporeal photochemotherapy increases response for chronic graft versus host disease following steroid failure

Gunduz M., Atilla E., Atilla P. A., Topcuoglu P., Ilhan O.

TRANSFUSION CLINIQUE ET BIOLOGIQUE, cilt.26, sa.1, ss.32-37, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.tracli.2018.03.005
  • Dergi Adı: TRANSFUSION CLINIQUE ET BIOLOGIQUE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.32-37
  • Anahtar Kelimeler: Graft versus host disease, Extracorporeal photochemotherapy, CONSENSUS DEVELOPMENT PROJECT, CLINICAL-TRIALS, CHRONIC GVHD, PHOTOPHERESIS, SURVIVAL, THERAPY, EFFICACY, CRITERIA, UPDATE, RISK
  • Ankara Üniversitesi Adresli: Evet

Özet

Objectives. - Chronic graft versus host disease (GVHD) is one of the major obstacles to achieve success in allogeneic hematopoietic stem cell transplantation (allo-HSCT). Extracorporeal photochemotherapy (ECP) has been demonstrated to be an effective modality for the treatment of GVHD in previous studies but they vary in terms of initiation and duration. Our aim is to demonstrate the characteristics of our patients who received ECP for chronic GVHD to clarify the best treatment scheme.